SANA
Income statement / Annual
Last year (2024), Sana Biotechnology, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Sana Biotechnology, Inc.'s net income was -$266.76 M.
See Sana Biotechnology, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$15.49 M
|
$30.87 M
|
$27.73 M
|
$17.91 M
|
$10.17 M
|
$3.92 M
|
$1.00 K
|
| Gross Profit |
-$15.49 M
|
-$30.87 M
|
-$27.73 M
|
-$17.91 M
|
-$10.17 M
|
-$3.92 M
|
-$1.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$217.56 M
|
$221.64 M
|
$201.00 M
|
$306.50 M
|
$257.88 M
|
$119.38 M
|
$4.01 M
|
| General & Administrative Expenses |
$64.04 M
|
$73.30 M
|
$71.56 M
|
$50.41 M
|
$28.27 M
|
$21.78 M
|
$8.41 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$64.04 M
|
$73.30 M
|
$71.56 M
|
$50.41 M
|
$28.27 M
|
$21.78 M
|
$4.21 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$674.00 K
|
$305.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$281.60 M
|
$294.94 M
|
$272.56 M
|
$356.91 M
|
$286.15 M
|
$141.15 M
|
$8.22 M
|
| Cost And Expenses |
$272.72 M
|
$325.81 M
|
$272.56 M
|
$356.91 M
|
$286.15 M
|
$141.15 M
|
$8.22 M
|
| Interest Income |
$10.47 M
|
$9.94 M
|
$3.76 M
|
$676.00 K
|
$747.00 K
|
$2.86 M
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$15.49 M
|
$30.87 M
|
$15.63 M
|
$11.07 M
|
$10.17 M
|
$3.92 M
|
$1.00 K
|
| EBITDA |
-$251.27 M |
-$252.39 M |
-$256.94 M |
-$345.84 M |
-$287.03 M |
-$138.90 M |
-$13.25 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$5.96 M
|
$43.65 M
|
$3.09 M
|
$981.00 K
|
$844.00 K
|
$2.83 M
|
-$5.03 M
|
| Income Before Tax |
-$266.76 M
|
-$283.26 M
|
-$269.48 M
|
-$355.93 M
|
-$285.31 M
|
-$138.33 M
|
-$13.25 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$7.55 M
|
$0.00
|
| Net Income |
-$266.76 M
|
-$283.26 M
|
-$269.48 M
|
-$355.93 M
|
-$285.31 M
|
-$130.78 M
|
-$13.25 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.16 |
-1.46 |
-1.43 |
-2.14 |
-1.63 |
-0.7 |
-0.0707 |
| EPS Diluted |
-1.16 |
-1.46 |
-1.43 |
-2.14 |
-1.63 |
-0.7 |
-0.0707 |
| Weighted Average Shares Out |
$230.89 M
|
$194.54 M
|
$188.34 M
|
$166.43 M
|
$187.51 M
|
$187.34 M
|
$187.34 M
|
| Weighted Average Shares Out Diluted |
$230.89 M
|
$194.54 M
|
$188.34 M
|
$166.43 M
|
$187.51 M
|
$187.34 M
|
$187.34 M
|
| Link |
|
|
|
|
|
|
|
